PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology (PR Newswire)

PAVmed has announced a letter of intent with Duke University to license a new endoscopic imaging technology that combines angle-resolved low coherence interferometry (a/LCI) with optical coherence tomography (OCT). Designed to detect and treat esophageal precancer (dysplasia) in real time, the technology could reduce reliance on traditional biopsies. Early studies led by Dr. Nicholas Shaheen and Dr. Adam Wax have shown high sensitivity and promising accuracy, with results from a pilot clinical trial submitted for publication.